Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results, page-18

Hi All,

You are on it @ Lastly. We have 75 ish patents. Now three potential individual orphan drug status candidates. Find me another "clinical stage" Company with this armature. You wont ! Certainly , not here in Australia. We are fourth in Australia in patents. But these are global leaders in research.

HTLV-1 has approximately 10 million sufferers throughout the World. Main prevalence is Romania/Southern Japan/ Caribbean/ Sub Sahara/ East/ South America/ PNG and Central Australia.

It infects T cells ( a type of white blood cell) and can cause Leukaemia and a Spinal Cord Paralysis syndrome. It is transmitted by blood transfusions, sharing needles , sexual contact and breast feeding.

There is no known cure.

There is no data you will find to estimate the value of a cure. I estimate a global response being 2.1 Billion USD.

What we have here fellow members is a pre clinical cure

Remember in 2012 Moderna was valued at a paltry $40 million. We are slowly showing our worth as a Company.

@ Jakjazz Transformed Leukaemia cell lines means this.

Ref : Leukaemia Transformation . Ying- Wei et Al 2004.

Great announcement Pharmaust. Recruiting another star player in the team.